Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics said this week that it has signed a non-exclusive supply agreement with Agilent Technologies for probe reagents for its FISH-based HPV-Associated Cancer Test (FHACT).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.